|
PLEKHM1P expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.2435999999999E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.61966999999708E-05 |
| Normal-vs-Stage2 |
9.939600E-01 |
| Normal-vs-Stage3 |
2.323800E-03 |
| Normal-vs-Stage4 |
8.016500E-04 |
| Stage1-vs-Stage2 |
1.242330E-03 |
| Stage1-vs-Stage3 |
3.416000E-01 |
| Stage1-vs-Stage4 |
8.521600E-01 |
| Stage2-vs-Stage3 |
1.508480E-02 |
| Stage2-vs-Stage4 |
5.000600E-03 |
| Stage3-vs-Stage4 |
3.823200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.49330000004588E-06 |
| Normal-vs-AfricanAmerican |
3.893400E-01 |
| Normal-vs-Asian |
1.151880E-04 |
| Caucasian-vs-AfricanAmerican |
1.195840E-02 |
| Caucasian-vs-Asian |
2.658600E-01 |
| AfricanAmerican-vs-Asian |
5.877500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.552400E-04 |
| Normal-vs-Female |
1.159370E-04 |
| Male-vs-Female |
8.653800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.42559999991721E-07 |
| Normal-vs-Age(41-60Yrs) |
5.616300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.133200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.125800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.436200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.422400E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.776400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.293700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.935400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.217000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.574600E-01 |
| Classical-VS-Follicular |
3.96309984829202E-10 |
| Classical-VS-Other |
8.934600E-01 |
| Classical-VS-Normal |
8.81010000508553E-08 |
| Tall-VS-Follicular |
2.988000E-04 |
| Tall-VS-Other |
5.524200E-01 |
| Tall-VS-Normal |
1.897880E-03 |
| Follicular-VS-Other |
3.214100E-02 |
| Follicular-VS-Normal |
4.772800E-01 |
| Other-VS-Normal |
1.660420E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.463900E-02 |
| Normal-vs-N1 |
1.77050000005341E-06 |
| N0-vs-N1 |
2.220800E-04 |
|
|
